Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophages and platelets in liver fibrosis and hepatocellular carcinoma. | Front Immunol | 2023 | 38116017 | PubTator, text mining | PubMed |
| Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus. | Front Immunol | 2023 | 38098483 | PubTator, text mining | PubMed |
| Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: Challenges and future prospects. | Cancer Innov | 2023 | 38090387 | PubTator, text mining | PubMed |
| Increased cardiovascular mortality during the COVID-19 pandemic: do not neglect causality. | Eur Heart J Open | 2023 | 38089856 | PubTator, text mining | PubMed |
| Engineered In Vitro Tumor Model Recapitulates Molecular Signatures of Invasion in Glioblastoma. | ACS Mater Au | 2023 | 38089093 | PubTator, text mining | PubMed |
| Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach. | Sci Rep | 2023 | 38081956 | PubTator, text mining | PubMed |
| PANoptosis in cancer, the triangle of cell death. | Cancer Med | 2023 | 38069556 | PubTator, text mining | PubMed |
| Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?-A Way to Trick the Host's Immune System. | Int J Mol Sci | 2023 | 38069400 | PubTator, text mining | PubMed |
| Crosstalk between Endothelial Cells and Tumor Cells: A New Era in Prostate Cancer Progression. | Int J Mol Sci | 2023 | 38069225 | PubTator, text mining | PubMed |
| Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment. | Int J Nanomedicine | 2023 | 38059000 | PubTator, text mining | PubMed |
| Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients. | Am J Cancer Res | 2023 | 38058831 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1. | BMC Cancer | 2023 | 38057830 | PubTator, text mining | PubMed |
| Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial. | Cell Rep Med | 2023 | 38056464 | PubTator, text mining | PubMed |
| TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties. | J Mammary Gland Biol Neoplasia | 2023 | 38055067 | PubTator, text mining | PubMed |
| The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. | Front Immunol | 2023 | 38053999 | PubTator, text mining | PubMed |
| Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma Mice. | Glob Med Genet | 2023 | 38046278 | PubTator, text mining | PubMed |
| Inferring a directed acyclic graph of phenotypes from GWAS summary statistics. | bioRxiv | 2023 | 38045347 | PubTator, text mining | PubMed |
| Identification of CXCL16 as a diagnostic biomarker for obesity and intervertebral disc degeneration based on machine learning. | Sci Rep | 2023 | 38044363 | PubTator, text mining | PubMed |
| Disruption of cholesterol homeostasis triggers periodontal inflammation and alveolar bone loss. | Exp Mol Med | 2023 | 38036731 | PubTator, text mining | PubMed |
| Exploring the mechanism of Liuwei Dihuang formula for promoting melanin synthesis in juvenile zebrafish based on network pharmacology and molecular docking. | Heliyon | 2023 | 38027573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=18